(Q44075228)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12135490%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

SF2/ASF protein inhibits camptothecin-induced DNA cleavage by human topoisomerase I (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12135490%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12135490%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

Barbara Kowalska-Loth

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12135490%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Agnieszka Piekiełko

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12135490%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Krzysztof Staroń

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12135490%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

English

0 references

publication date

1 July 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12135490%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12135490%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

269

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12135490%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12135490%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

3504-3510

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12135490%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03037.X

Topoisomerase I inhibitors: review and update

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03037.X

Mammalian DNA topoisomerase I activity and poisoning by camptothecin are inhibited by simian virus 40 large T antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03037.X

Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03037.X

Serine phosphorylation of SR proteins is required for their recruitment to sites of transcription in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03037.X

The subcellular localization of SF2/ASF is regulated by direct interaction with SR protein kinases (SRPKs)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03037.X

Functional expression of cloned human splicing factor SF2: homology to rna-binding proteins, U1 70K, and drosophila splicing regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03037.X

Interaction between the N-terminal domain of human DNA topoisomerase I and the arginine-serine domain of its substrate determines phosphorylation of SF2/ASF splicing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03037.X

A functional linker in human topoisomerase I is required for maximum sensitivity to camptothecin in a DNA relaxation assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03037.X

Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03037.X

Sequence-specific RNA binding by an SR protein requires RS domain phosphorylation: creation of an SRp40-specific splicing enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03037.X

DNA relaxation and cleavage assays to study topoisomerase I inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03037.X

Functional cooperation between topoisomerase I and single strand DNA-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03037.X

Topoisomerase inhibitors induce irreversible fragmentation of replicated DNA in concanavalin A stimulated splenocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03037.X

Residues within the N-terminal Domain of Human Topoisomerase I Play a Direct Role in Relaxation*

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03037.X

Binding of ATP to human DNA topoisomerase I resulting in an alteration of the conformation of the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03037.X

Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03037.X

Topoisomerase I is differently phosphorylated in two sublines of L5178Y mouse lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03037.X

Contribution of topoisomerase I to conversion of single-strand into double-strand DNA breaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03037.X

Involvement of amino acids 361 to 364 of human topoisomerase I in camptothecin resistance and enzyme catalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03037.X

Vaccinia DNA topoisomerase I: kinetic evidence for general acid-base catalysis and a conformational step

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03037.X